340 related articles for article (PubMed ID: 31813456)
1. Unmasking the Many Faces of Tumor-Associated Neutrophils and Macrophages: Considerations for Targeting Innate Immune Cells in Cancer.
Keeley T; Costanzo-Garvey DL; Cook LM
Trends Cancer; 2019 Dec; 5(12):789-798. PubMed ID: 31813456
[TBL] [Abstract][Full Text] [Related]
2. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
[TBL] [Abstract][Full Text] [Related]
3. AIRE is expressed in breast cancer TANs and TAMs to regulate the extrinsic apoptotic pathway and inflammation.
Källberg E; Mehmeti-Ajradini M; Björk Gunnarsdottir F; Göransson M; Bergenfelz C; Allaoui Fredriksson R; Hagerling C; Johansson ME; Welinder C; Jirström K; Leandersson K
J Leukoc Biol; 2024 Mar; 115(4):664-678. PubMed ID: 38060995
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Associated Neutrophils and Macrophages-Heterogenous but Not Chaotic.
Wu L; Zhang XH
Front Immunol; 2020; 11():553967. PubMed ID: 33343560
[TBL] [Abstract][Full Text] [Related]
5. Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy.
Lebegge E; Arnouk SM; Bardet PMR; Kiss M; Raes G; Van Ginderachter JA
Front Immunol; 2020; 11():1395. PubMed ID: 32733461
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and Cancer.
Rogers T; DeBerardinis RJ
Trends Cancer; 2021 Aug; 7(8):700-713. PubMed ID: 34023325
[TBL] [Abstract][Full Text] [Related]
7. Phagocytes as Corrupted Policemen in Cancer-Related Inflammation.
Bonavita E; Galdiero MR; Jaillon S; Mantovani A
Adv Cancer Res; 2015; 128():141-71. PubMed ID: 26216632
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of Macrophage Density in the Absence of Neutrophils in Differentiated Thyroid Cancer.
Onuma AE; Schoenfield L; Shen C; Edwards C; Phay JE; Shirley LA; Tsung A
J Surg Res; 2020 Dec; 256():458-467. PubMed ID: 32798993
[TBL] [Abstract][Full Text] [Related]
9. Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune Cells.
Liang W; Ferrara N
Front Immunol; 2020; 11():626812. PubMed ID: 33679721
[TBL] [Abstract][Full Text] [Related]
10. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
[TBL] [Abstract][Full Text] [Related]
11. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
[TBL] [Abstract][Full Text] [Related]
12. Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer.
Orozco-Morales M; Soca-Chafre G; Barrios-Bernal P; Hernández-Pedro N; Arrieta O
Mediators Inflamm; 2016; 2016():3494608. PubMed ID: 26941482
[TBL] [Abstract][Full Text] [Related]
13. Histamine in cancer immunology and immunotherapy. Current status and new perspectives.
Sarasola MP; Táquez Delgado MA; Nicoud MB; Medina VA
Pharmacol Res Perspect; 2021 Oct; 9(5):e00778. PubMed ID: 34609067
[TBL] [Abstract][Full Text] [Related]
14. Molecular Repolarisation of Tumour-Associated Macrophages.
van Dalen FJ; van Stevendaal MHME; Fennemann FL; Verdoes M; Ilina O
Molecules; 2018 Dec; 24(1):. PubMed ID: 30577495
[TBL] [Abstract][Full Text] [Related]
15. Activation of phagocytosis by immune checkpoint blockade.
Li CW; Lai YJ; Hsu JL; Hung MC
Front Med; 2018 Aug; 12(4):473-480. PubMed ID: 30062558
[TBL] [Abstract][Full Text] [Related]
16. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Associated Neutrophils Drive B-cell Recruitment and Their Differentiation to Plasma Cells.
Shaul ME; Zlotnik A; Tidhar E; Schwartz A; Arpinati L; Kaisar-Iluz N; Mahroum S; Mishalian I; Fridlender ZG
Cancer Immunol Res; 2021 Jul; 9(7):811-824. PubMed ID: 33906865
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated neutrophils: orchestrating cancer pathobiology and therapeutic resistance.
Bui TM; Yalom LK; Sumagin R
Expert Opin Ther Targets; 2021 Jul; 25(7):573-583. PubMed ID: 34236924
[No Abstract] [Full Text] [Related]
19. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
[TBL] [Abstract][Full Text] [Related]
20. Rational targeting of immunosuppressive neutrophils in cancer.
Zhao Y; Rahmy S; Liu Z; Zhang C; Lu X
Pharmacol Ther; 2020 Aug; 212():107556. PubMed ID: 32343986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
